Clinical Trial

Pathophysiology of Dysautonomia and Postural Tachycardia Syndrome (POTS) in Post-viral Syndromes and COVID-19

Study acronym: fBRI
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to better understand the biological mechanisms underlying dysautonomia and postural orthostatic tachycardia syndrome (POTS), including how these conditions may be related to COVID-19. Participants will attend a single research visit lasting approximately one hour, during which a blood sample will be collected for immune system and genetic analyses. Information from participants' medical records may also be reviewed to support the research. The knowledge gained from this study may help improve understanding, diagnosis, and treatment of dysautonomia in the future.
Trial Details
NCT Number NCT07405515
Lead Sponsor Brigham and Women's Hospital
Collaborators: FBRI LLC (F-Prime Capital)
Conditions POTS, POTS - Postural Orthostatic Tachycardia Syndrome, Dysautonomia, Autonomic Dysfunction
Enrollment 100 participants
Start Date 2024-02-02
Primary Completion 2025-07-21 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-12